Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Discrepancy between clinical and radiological responses to tocilizumab treatment in patients with systemic-onset juvenile idiopathic arthritis.

Aoki C, Inaba Y, Choe H, Kaneko U, Hara R, Miyamae T, Imagawa T, Mori M, Oba MS, Yokota S, Saito T.

J Rheumatol. 2014 Jun;41(6):1171-7. doi: 10.3899/jrheum.130924. Epub 2014 May 1. Erratum in: J Rheumatol. 2014 Jul;41(7):1567.

PMID:
24786929
2.

Radiologic analysis of the effect of tocilizumab on hands and large joints in children with systemic juvenile idiopathic arthritis.

Inaba Y, Ozawa R, Aoki C, Imagawa T, Mori M, Hara R, Miyamae T, Saito T, Yokota S.

Mod Rheumatol. 2013 Jul;23(4):667-73. doi: 10.1007/s10165-012-0711-0. Epub 2012 Jul 13.

PMID:
22791270
3.

Longterm safety and effectiveness of the anti-interleukin 6 receptor monoclonal antibody tocilizumab in patients with systemic juvenile idiopathic arthritis in Japan.

Yokota S, Imagawa T, Mori M, Miyamae T, Takei S, Iwata N, Umebayashi H, Murata T, Miyoshi M, Tomiita M, Nishimoto N, Kishimoto T.

J Rheumatol. 2014 Apr;41(4):759-67. doi: 10.3899/jrheum.130690. Epub 2014 Mar 15.

PMID:
24634205
4.

Radiographic improvement of damaged large joints in children with systemic juvenile idiopathic arthritis following tocilizumab treatment.

Inaba Y, Ozawa R, Imagawa T, Mori M, Hara Y, Miyamae T, Aoki C, Saito T, Yokota S.

Ann Rheum Dis. 2011 Sep;70(9):1693-5. doi: 10.1136/ard.2010.145359. Epub 2011 Mar 14. No abstract available.

PMID:
21402562
5.

Comparisons of the outcomes between early and late tocilizumab treatment in systemic juvenile idiopathic arthritis.

Pacharapakornpong T, Vallibhakara SA, Lerkvaleekul B, Vilaiyuk S.

Rheumatol Int. 2017 Feb;37(2):251-255. doi: 10.1007/s00296-016-3595-z. Epub 2016 Oct 31.

PMID:
27798725
6.

Safety of tocilizumab in the treatment of juvenile idiopathic arthritis.

Machado SH, Xavier RM.

Expert Opin Drug Saf. 2017 Apr;16(4):493-500. doi: 10.1080/14740338.2017.1303479. Review.

PMID:
28277841
7.

Effect of tocilizumab on growth impairment in systemic juvenile idiopathic arthritis with long-term corticosteroid therapy.

Miyamae T, Yokoya S, Yamanaka H, Yokota S.

Mod Rheumatol. 2014 Jul;24(4):567-71. doi: 10.3109/14397595.2013.844404. Epub 2013 Oct 21.

PMID:
24252004
8.

Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab.

Yokota S, Itoh Y, Morio T, Sumitomo N, Daimaru K, Minota S.

J Rheumatol. 2015 Apr;42(4):712-22. doi: 10.3899/jrheum.140288. Epub 2015 Feb 15.

PMID:
25684767
9.

Effect of interleukin-6 receptor inhibitor, tocilizumab, in preventing joint destruction in patients with rheumatoid arthritis showing inadequate response to TNF inhibitors.

Tanaka Y, Takeuchi T, Amano K, Saito K, Hanami K, Nawata M, Fukuyo S, Kameda H, Kaneko Y, Kurasawa T, Nagasawa H, Hoshi D, Sato E, Yamanaka H.

Mod Rheumatol. 2014 May;24(3):399-404. doi: 10.3109/14397595.2013.843757. Epub 2013 Nov 5.

PMID:
24252045
10.

Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.

Tappeiner C, Mesquida M, Adán A, Anton J, Ramanan AV, Carreno E, Mackensen F, Kotaniemi K, de Boer JH, Bou R, de Vicuña CG, Heiligenhaus A.

J Rheumatol. 2016 Dec;43(12):2183-2188. Epub 2016 Sep 15.

PMID:
27633821
11.

Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis.

Kostik MM, Dubko MF, Masalova VV, Snegireva LS, Kornishina TL, Chikova IA, Isupova EA, Kuchinskaya EM, Glebova NI, Buchinskaya NV, Kalashnikova OV, Chasnyk VG.

Pediatr Rheumatol Online J. 2015 Jan 23;13:4. doi: 10.1186/1546-0096-13-4. eCollection 2015.

12.

IL-6 blockers in systemic onset juvenile idiopathic arthritis.

Barone P, Pignataro R, Garozzo MT, Leonardi S.

Immunotherapy. 2016;8(1):79-87. doi: 10.2217/imt.15.104. Epub 2015 Dec 7. Review.

PMID:
26642378
13.

Use of the Sharp and Larsen scoring methods in the assessment of radiographic progression in juvenile idiopathic arthritis.

Rossi F, Di Dia F, Galipò O, Pistorio A, Valle M, Magni-Manzoni S, Ruperto N, Tomà P, Martini A, Ravelli A.

Arthritis Rheum. 2006 Oct 15;55(5):717-23.

14.

Power Doppler ultrasonography is useful for assessing disease activity and predicting joint destruction in rheumatoid arthritis patients receiving tocilizumab--preliminary data.

Hama M, Uehara T, Takase K, Ihata A, Ueda A, Takeno M, Shizukuishi K, Tateishi U, Ishigatsubo Y.

Rheumatol Int. 2012 May;32(5):1327-33. doi: 10.1007/s00296-011-1802-5. Epub 2011 Feb 4.

15.

Tocilizumab in systemic juvenile idiopathic arthritis in a real-world clinical setting: results from 1 year of postmarketing surveillance follow-up of 417 patients in Japan.

Yokota S, Itoh Y, Morio T, Origasa H, Sumitomo N, Tomobe M, Tanaka K, Minota S.

Ann Rheum Dis. 2016 Sep;75(9):1654-60. doi: 10.1136/annrheumdis-2015-207818. Epub 2015 Dec 7.

16.

[Relationship of the clinical efficiency of tocilizumab therapy to the serum level of matrix metalloproteinase-3 in patients with rheumatoid arthritis].

Avdeeva AS, Aleksandrova EN, Novikov AA, Cherkasova MV, Panasyuk EY, Nasonov EL.

Ter Arkh. 2013;85(5):24-9. Russian.

PMID:
23819335
17.
18.

Frequency of radiographic damage and progression in individual joints in children with juvenile idiopathic arthritis.

Giancane G, Pederzoli S, Norambuena X, Ioseliani M, Sato J, Gallo MC, Negro G, Pistorio A, Ruperto N, Martini A, Ravelli A.

Arthritis Care Res (Hoboken). 2014 Jan;66(1):27-33. doi: 10.1002/acr.22123.

19.

Development and initial validation of a radiographic scoring system for the hip in juvenile idiopathic arthritis.

Bertamino M, Rossi F, Pistorio A, Lucigrai G, Valle M, Viola S, Magni-Manzoni S, Malattia C, Martini A, Ravelli A.

J Rheumatol. 2010 Feb;37(2):432-9. doi: 10.3899/jrheum.090691. Epub 2009 Dec 23.

PMID:
20032107
20.

Systematic review of tocilizumab for rheumatoid arthritis: a new biologic agent targeting the interleukin-6 receptor.

Navarro-Millán I, Singh JA, Curtis JR.

Clin Ther. 2012 Apr;34(4):788-802.e3. doi: 10.1016/j.clinthera.2012.02.014. Epub 2012 Mar 22. Review.

Supplemental Content

Support Center